Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. The company's first commercial product, COPIKTRA (duvelisib) is indicated for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia/... Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. The company's first commercial product, COPIKTRA (duvelisib) is indicated for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma after at least two prior therapies and relapsed or refractory follicular lymphoma after at least two prior systemic therapies. The company's product pipeline candidate, defactinib, is a focal adhesion kinase inhibitor in development for the treatment of cancers where there are limited treatment options, including lung, ovarian, lymphoma, pancreatic, and other advanced cancers. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 1.59 | 29.6641791045 | 5.36 | 7.13 | 5.3 | 1316116 | 6.22854269 | CS |
| 4 | 0.86 | 14.1215106732 | 6.09 | 7.13 | 5.3 | 680122 | 5.97593663 | CS |
| 12 | 2.52 | 56.8848758465 | 4.43 | 7.26 | 3.455 | 1399620 | 5.58310356 | CS |
| 26 | 4.55 | 189.583333333 | 2.4 | 7.26 | 2.4 | 1149489 | 4.74903262 | CS |
| 52 | -5.8 | -45.4901960784 | 12.75 | 13.52 | 2.1 | 870468 | 4.56231712 | CS |
| 156 | -6.37 | -47.8228228228 | 13.32 | 25.56 | 2.1 | 1093385 | 9.87838393 | CS |
| 260 | -30.25 | -81.3172043011 | 37.2 | 59.22 | 2.1 | 2006682 | 21.3061637 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
